Randomized Trial of Unmanipulated Mobilized Blood/Marrow Versus Blood Haploidentical Transplant With Standard-risk Leukemia
The donors were primed with granulocyte-colony stimulating factor (G-CSF) injected
subcutaneously for five consecutive days. In the trial group, the PBSCs were harvested on
the fourth and fifth day;in the control group, the bone marrow cells were harvested on the
fourth day and the PBSCs were harvested on the fifth day.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
incidence of engraftment
number of participants with engraftment at 30d
paticipants will be followed for the duration of hospital stay,an expected average of 30 days
Xiao-Jun Huang, M.D.
Peking University People's Hospital
China: Ministry of Health
PUPH IRB  (27)